Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis

—European Patent Office Grants New Patent Covering Use of CM-101 for the Treatment of Multiple Liver Diseases including Primary Sclerosing Cholangitis— —Further Extends Protections Afforded by...

Related Keywords

China ,Israel ,Wadi Mor ,Barbara Lindheim ,European Patent Office Grants New Covering ,Nasdaq ,European Patent Office ,Strategic Communications ,Chemomab Therapeutics Ltd ,Multiple Liver ,Primary Sclerosing Cholangitis ,Further Extends Protections Afforded ,Use Patents ,That Have Issued ,Related Territories ,Chief Executive Officer ,Chief Scientific Officer ,Patent Application ,Orphan Drug ,Private Securities Litigation Reform ,Vice President ,Public Relations ,Markets ,